NCT05733715 · Interventional trial
Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma
Overall registry status Recruiting
Early Phase 1
Conditions Renal Cell Carcinoma
Delaware Valley sites
- Abramson Cancer Center at University of Pennsylvania · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory